bSys
bSys GmbH is a privately owned company headquartered in Basel, Switzerland. As a contract research organization (CRO) bSys provides assistance to pharmaceutical settings in Ion Channel Discovery. The...
www.bsys.ch/ View full profile
| |
Bucher Biotec AG
Bucher Biotec AG is a privately held, well established Swiss distributor company representing major US, European and Japanese manufacturers of scientific instruments and associated consumables for...
www.bucher.ch/ View full profile
| |
Cambria Biosciences
Cambria Biosciences is an innovative biotechnology company that combines the power of genetics, physiological disease models and high-throughput chemical screening to discover new drug leads and how...
www.cambriabio.com/ View full profile
| |
CARA Therapeutics
Cara possesses both near-term clinical development opportunities, combined with proprietary approaches to developing first-in-class novel therapeutics. Cara's first patented compound, CR665, has...
www.caratherapeutics.com/ View full profile
| |
Card Guar
Card Guard, is listed on the Swiss Stock Exchange having its wholly-owned subsidiaries in the United States, the Netherlands, Japan, Brazil, including its R&D center in Israel. Among its subsidiaries...
www.cardguard.com/ View full profile
| |
CAYLA S.A.S.
Founded in 1977 by French scientists, CAYLA is an independant company aiming at exploiting its scientific and technical know-how through the design and development of innovative products and processes...
www.cayla.com/ View full profile
| |
CDS Analytical, Inc.
CDS Analytical, Inc. has been a leader in the design and manufacture of laboratory instruments for sample preparation and analysis for over 30 years. While best known in the field of analytical...
www.cdsanalytical.com/ View full profile
| |
CyBio
With almost 20 years of experience CyBio develops, produces and sells technology platforms for drug discovery.
The portfolio covers a broad range of solutions for pharmaceutical and agrochemical...
www.cybio-ag.com/ View full profile
| |
DIAMICS, INC
Diamics mission is to work in partnership with both individual and institutional experts to develop and market cost-effective molecular-based cancer screening and diagnostic systems that will increase...
www.diamics.com/ View full profile
| |
Cellomics
Cellomics, a business unit within the Fisher Biosciences group, provides complete systems for High Content Screening (HCS) and Analysis (HCA) to drug discovery and systems biology researchers. The...
www.cellomics.com/ View full profile
| |
Cellumen, Inc.
Cellumen is a systems cell biology company that is focused on defining the functions of genes, coding and non-coding RNA's, proteins and other cellular constituents that regulate and perform the...
www.cellumen.com/ View full profile
| |
CellZome AG
Cellzome is a privately-owned drug discovery company identifying a new generation of kinase- targeted drugs to treat inflammatory diseases. Its pipeline of small-molecule therapeutics is driven by...
www.cellzome.com/ View full profile
| |
Cerep Inc
Cerep is a drug discovery company with a comprehensive platform of technologies, services, and expertise to synthesize, identify and optimize compounds most likely to succeed in drug development...
www.cerep.com/ View full profile
| |
Cerep Inc
Cerep is a drug discovery company with a comprehensive platform of technologies, services, and expertise to synthesize, identify and optimize compounds most likely to succeed in drug development...
www.cerep.fr/ View full profile
| |
Cetek Corporation
Cetek is a discovery and development stage pharmaceutical company built on proven innovative technologies. Cetek’s approach integrates its proprietary capillary electrophoresis screening (CE Assay)...
www.cetek.com/ View full profile
| |
